Skip to main content
OpenTrials
Completed

NCT Number: NCT01115660

Stroke Education Intervention Trial - Pilot

The objectives of the trial of a medication-coach program for patients with stroke or transient ischemic attack are to pilot test the study design, the intervention components and the data collection forms and refine them for a larger trial whose goal will be to improve long-term adherence to stroke prevention medications.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Ischemic Stroke Behavior Brain Diseases Brain Ischemia Cardiovascular Diseases Central Nervous System Diseases Cerebrovascular Disorders Health Behavior Hemorrhage Intracranial Hemorrhage Intracranial Hemorrhages Ischemic Attack, Transient Medication Adherence Nervous System Diseases Pathologic Processes Pathological Conditions, Signs and Symptoms Patient Acceptance of Health Care Patient Compliance Stroke Transient Ischemic Attack Treatment Adherence and Compliance Vascular Diseases

Age range

19 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

WFUBMC

Winston-Salem, North Carolina, 27157, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients at Wake Forest University Baptist Medical Center (WFUBMC) over age 18
  • Diagnosed with acute ischemic stroke, transient ischemic attack or intracranial hemorrhage
  • provide consent to participate

Exclusion criteria

  • discharged to nursing home, acute rehabilitation center, inpatient hospice, or other acute hospital
  • homeless
  • non-English speakers
  • patient and proxy unable to participate in telephone conversation

Treatment and study plan

Stroke education

Behavioral

call by medication coach 2 weeks after hospital discharge

Primary outcomes

  1. Feasibility of Intervention (Ability to Reach Patients at 3 Months)

    Time frame: 3 months

    Number of patients contacted at 3 months

Secondary outcomes

  1. Follow up Appointment With MD

    Time frame: 3 months

    Follow up appointment with primary care provider since stroke

Sponsors and collaborators

Lead sponsor

Duke University

Other

Collaborators

  • Wake Forest University Health Sciences

Registry information

Official study title

AVAIL interVention Trial (Adherence Evaluation After Ischemic Stroke - Longitudinal): Pilot Protocol

Acronym: AVAIL II

Important dates

Study start
2010
Primary completion
2011
Study completion
2011
First posted
May 4, 2010
Registry last updated
Oct 14, 2015

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.